Acelyrin, Inc.
SLRN
$2.69
-$0.06-2.18%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 57.77% | 170.40% | 292.47% | 366.37% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.15% | 209.28% | 246.85% | 317.05% | -- |
| Operating Income | -63.15% | -209.28% | -246.85% | -317.05% | -- |
| Income Before Tax | 13.66% | -26.66% | -6.67% | -489.21% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.66% | -26.66% | -6.67% | -489.21% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.66% | -26.66% | -6.67% | -489.21% | -- |
| EBIT | -63.15% | -209.28% | -246.85% | -317.05% | -- |
| EBITDA | -139.98% | -789.07% | -- | -- | -- |
| EPS Basic | 86.54% | 88.75% | 92.77% | 76.00% | -- |
| Normalized Basic EPS | 77.00% | 82.80% | 89.52% | 90.65% | -- |
| EPS Diluted | 86.54% | 88.75% | 92.77% | 76.00% | -- |
| Normalized Diluted EPS | 77.00% | 82.80% | 89.52% | 90.65% | -- |
| Average Basic Shares Outstanding | 113.77% | 337.78% | 1,285.25% | 4,403.73% | -- |
| Average Diluted Shares Outstanding | 113.77% | 337.78% | 1,285.25% | 4,403.73% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
